Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2010 | 08-2010 | 05-2010 | 02-2010 | 11-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98 | 412 | 701 | 987 | 126 |
| Other current assets | 0 | 8 | 1,824 | 100 | 0 |
| TOTAL | $132 | $437 | $2,544 | $1,115 | $149 |
| Non-Current Assets | |||||
| PPE Net | 7 | 7 | 4 | 4 | 3 |
| Other Non-Current Assets | 20 | 22 | 24 | 26 | 28 |
| TOTAL | $27 | $29 | $28 | $30 | $31 |
| Total Assets | $159 | $465 | $2,572 | $1,145 | $180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 149 | 154 | 154 | 194 | 191 |
| Accounts payable and accrued liabilities | 272 | 192 | 205 | 290 | 340 |
| Accrued Expenses | 13 | 10 | 1,195 | 78 | 78 |
| Other current liabilities | N/A | N/A | 3,997 | N/A | N/A |
| TOTAL | $435 | $356 | $5,551 | $575 | $636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7 | 7 | 236 | 236 | 236 |
| TOTAL | $7 | $7 | $236 | $236 | $236 |
| Total Liabilities | $442 | $363 | $5,787 | $811 | $872 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,371 | 20,952 | 20,942 | 20,574 | 20,452 |
| Common Shares | 7,940 | 7,342 | 7,145 | 6,855 | 6,718 |
| Retained earnings | -15,535 | -14,478 | -13,241 | -11,882 | -11,165 |
| Other shareholders' equity | 1,618 | 1,759 | -2,137 | 1,802 | 358 |
| TOTAL | $-283 | $102 | $-3,216 | $334 | $-693 |
| Total Liabilities And Equity | $159 | $465 | $2,572 | $1,145 | $180 |